The global head of research and development at Atara Biotherapeutics discussed ATA188 ahead of anticipated data readouts this month.
Neurology
Latest News
Advertisement
Advertisement
Review top news and interview highlights from the week ending July 1, 2022.
A patient showed more than a 50% reduction in N-acetylaspartate (NAA) in brain white matter at 3 months post-treatment.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
It will be the first AMN clinical study to utilize wearable technology for monitoring patient activity and outcomes.
Benjamin Harrison, BSc, PhD, assistant professor of biochemistry and nutrition at UNE, shared his thoughts on the research.
Susan Ruediger, founder and chief mission officer, CMT Research Foundation, discussed the panel discussion she participated in at BIO 2022.
The hold comes after a serious AE of peripheral sensory neuropathy.
Review top news and interview highlights from the week ending June 24, 2022.
Huntington Disease Gene Therapy Promotes Reduction in Mutant Huntington Protein, Neurofilament Light
NfL peaked 1-month post-treatment as expected and returned to near baseline at 12 months.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
The chief scientific officer of the CMT Research Foundation discussed investigative cell and gene therapy approaches for treating CMT.
Review top news and interview highlights from the week ending June 17, 2022.
The approval came earlier than the recently extended PDUFA date of July 24, 2022.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
The trial was placed on hold after elevated liver function test scores.
Review top news and interview highlights from the week ending June 10, 2022.
The FDA's Cellular, Tissue, and Gene Therapies Advisory Committee voted in favor of the benefits of bluebird bio's eli-cel in patients with cerebral andrenoleukodystrophy despite substantial safety concerns.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Review top news and interview highlights from the week ending June 3, 2022.
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Stefan Braam, PhD, chief executive officer of Ncardia and Cellistic discussed the companies’ work in the cell therapy space.
Review top news and interview highlights from the week ending May 27, 2022.
The chief executive officer of Ring Therapeutics, Tuyen Ong, MD, discussed the potential of anellovirus vectors for use in gene therapy.
The vice president of neuroscience at Sangamo Therapeutics discussed identifying novel capsids with improved neuronal transduction to the CNS.
Advertisement
Advertisement
